N@N

Vamil Divan Maintained (ABBV) at Strong Buy with Increased Target to $110 on, Jun 29th, 2020

Vamil Divan of Mizuho, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $101 to $110 on, Jun 29th, 2020.

Vamil has made no other calls on ABBV in the last 4 months.

There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 2 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Jason Gerberry of "B of A Securities" Initiated at Hold and Held Target at $95 on, Monday, May 18th, 2020
• Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020

These are the ratings of the 6 analyists that currently disagree with Vamil

---

• Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $125 on, Thursday, June 25th, 2020
• Steve Chesney of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $115 on, Tuesday, June 23rd, 2020
• Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Wednesday, June 17th, 2020
• David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $115 on, Tuesday, June 2nd, 2020
• Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Monday, May 11th, 2020
• David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $95 on, Monday, May 11th, 2020

Contributing Sources

---